Adaptive Biotechnologies IPO

adaptivebiotech.com

Adaptive Biotechnologies is a biotechnology company specializing immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.

Founded2009
Total Funding to Date$561.37MM
Register for Details

For more details on financing and valuation for Adaptive Biotechnologies, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Adaptive Biotechnologies Ticker Symbol

Adaptive Biotechnologies does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Adaptive Biotechnologies Stock Price

The stock price for Adaptive Biotechnologies will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Adaptive Biotechnologies Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/4/2018 Series F-1 $1.35B $XXX.XX $XXX.XX
5/6/2015 Series F $1.08B $XXX.XX $XXX.XX
1/22/2015 Series E1 $652.13MM $XXX.XX $XXX.XX
1/21/2015 Series E $321.37MM $XXX.XX $XXX.XX
7/29/2014 Series D $261.89MM $XXX.XX $XXX.XX
7/9/2013 Series C $76.08MM $XXX.XX $XXX.XX
6/2/2011 Series B $49.04MM $XXX.XX $XXX.XX
3/24/2010 Series A $27.52MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Adaptive Biotechnologies in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B